Assessment of GCC pharmaceutical market for a global European pharma major

  • Analysed potential for entry into the GCC pharmaceutical market

  • Helped client understand socio-economic and health policies in GCC countries


CLIENT CHALLENGES
  • A global European pharma major wanted to assess the market’s viability as an investment opportunity
  • Key challenges were :
    • Scarcity of data in GCC countries
    • Highly fragmented pharmaceutical markets in GCC countries
    • The need to understand socio-economic determinants and government policies
OUR APPROACH
  • Market assessment :
    • Estimated market size using the bottom-up approach
    • Assessed market dynamics, drivers and barrier to entry
    • Assessed the top players in market, their revenue streams and plans
    • Assessed sub-sectors based on competition
  • Socio-economic determinants :
    • Tracked spending as a percentage of GDP on the healthcare sector and per capita expenditure on healthcare
    • Gained an understanding of the proportion of the aged population and incidence of chronic disease
    • Analysed participation of private hospitals and health insurance
  • Government/health policies :
    • Tracked healthcare-related policies
    • Tracked regulatory, pricing and reimbursement policies
    • Gained an understanding of government policies in terms of setting up manufacturing bases and foreign investments
IMPACT DELIVERED
  • Advised on sub-sectors with unmet need and market attractiveness
  • Assessed possible market drivers and barriers to entry
Thank you for sharing your details

Your file will start downloading automatically

If it does not download within 1 minute,

Share this on

What we have done

Competitor benchmarking and performance gap analysis for a leading European medical device player
What we are proud of

Improved customer perception

Increase in sales for client

Opportunity assessment and market attractiveness for one of the top 10 pharmaceutical major
What we are proud of

Improved customer perception

Increase in sales for client

Assessing viability of entering the NSCLC market
What we are proud of

Improved customer perception

Increase in sales for client

Supplier assessment and industry benchmarking for a global top 10 pharmaceutical company
What we are proud of

Improved customer perception

Increase in sales for client

Product launch strategy for European biopharmaceutical company
What we are proud of

Improved customer perception

Increase in sales for client

Research on a multiple sclerosis drug with help from global neurologists
What we are proud of

Improved customer perception

Increase in sales for client

Patient treatment pathway analysis for venom allergies
What we are proud of

Improved customer perception

Increase in sales for client